Brandi L. Roberts
2023 - Longboard Pharmaceuticals
In 2023, Brandi L. Roberts earned a total compensation of $1M as Executive Vice President and Chief Financial Officer at Longboard Pharmaceuticals, a 19% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $211,411 |
|---|---|
| Option Awards | $362,547 |
| Salary | $436,800 |
| Other | $14,442 |
| Total | $1,025,200 |
Roberts received $436.8K in salary, accounting for 43% of the total pay in 2023.
Roberts also received $211.4K in non-equity incentive plan, $362.5K in option awards and $14.4K in other compensation.
Rankings
In 2023, Brandi L. Roberts' compensation ranked 1,186th out of 3,006 executives tracked by ExecPay. In other words, Roberts earned more than 60.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,186 out of 3,006 | 61st |
Division Manufacturing | 707 out of 1,650 | 57th |
Major group Chemicals And Allied Products | 475 out of 918 | 48th |
Industry group Drugs | 463 out of 881 | 47th |
Industry Pharmaceutical Preparations | 318 out of 637 | 50th |
Source: SEC filing on April 12, 2024.
Roberts' colleagues
We found two more compensation records of executives who worked with Brandi L. Roberts at Longboard Pharmaceuticals in 2023.
News
Longboard Pharmaceuticals CEO Kevin Lind's 2023 pay jumps 36% to $2.1M
April 12, 2024
Longboard Pharmaceuticals CEO Kevin Lind's 2022 pay jumps 72% to $1.5M
April 11, 2023
Longboard Pharmaceuticals CFO Brandi Roberts receives $1.3M in 2021
April 13, 2022
BioTime CFO Brandi Roberts receives $948K in 2019
August 7, 2020